Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.
Does finerenone improve outcomes in patients withheart failure (HF) with mildly reduced or preserved ejection fraction?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback